Food Hypersensitivity Clinical Trial
Official title:
Importance and Association of Gut Microbiota and Biochemical Metabolites on Children Allergic Disorder
Verified date | June 2022 |
Source | Chang Gung Memorial Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Food allergies account for only a small percentage of all adverse reactions to foods and their prevalence has increased over the past 10-15 years, particularly in industrialized countries: 3-6% of children under 3 years of age and 1-3% of adults. Food allergens in children are represented by milk, egg, wheat, soy, peanuts, tree nuts, fish, and shellfish. The majority of allergic processes that develop during the childhood tend to abate with age, whereas those that occur during adulthood tend to persist. Hypersensitivity refers to an excessive immunological reaction to food antigens with undesirable consequences. The first aim of our study is to evaluate the role of intestinal microbiota and their relationship with immune tolerance or allergic disorder. The second aim of our study is determining the biochemical metabolites on the host (human being) in allergic disorder, and these biochemical metabolites can be measured in fecal or urine samples by metabolomics methods. We try to seek to gain an advanced understanding of gut microbiota and biochemical metabolites associated with mucosal immune responses in the host. These findings could be useful for developing strategies to modify the gut microbiota or medical applications (e.g. healthy microbe preparations) involving beneficial microorganisms to control the development of allergic disorders.
Status | Completed |
Enrollment | 120 |
Est. completion date | July 31, 2019 |
Est. primary completion date | July 31, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 6 Months to 6 Years |
Eligibility | Inclusion Criteria: Children with immune tolerance; Children with food hypersensitivity Children with food allergy Children with allergic disorder Healthy volunteers (Children) Exclusion Criteria: Exclusively vegetarian was not enrolled in this study. - |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Chang Gung Memorial Hospital |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | microbiota | Taxonomy-based analyses were performed by classifying each sequence using the RDP Naïve Bayesian rRNA Classifier Version 2.5 program | "baseline, pre-intervention" | |
Primary | Biochemical Metabolites | The identity of compounds will be confirmed by LC/MS/MS by using a QTOF (model 6510,Agilent). The water-soluble fraction of the fecal samples will be analyzed using 1H Nuclear magnetic resonance (NMR) spectroscopy. | "baseline, pre-intervention" |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01904604 -
Peanut Epicutaneous Phase II Immunotherapy Clinical Trial
|
Phase 2 | |
Enrolling by invitation |
NCT04885959 -
The Effects of Traditional Asian Diet on Gut Microbiome and Metabolome in Healthy Volunteers and Pregnancy on Subsequent Infant's Allergy Development
|
N/A | |
Recruiting |
NCT03974555 -
Epidemiological Investigation and Cohort Study on Food Allergy in Children Aged 3 to 6 Years in Wenzhou and Taizhou Urban Areas
|
||
Recruiting |
NCT05177744 -
Toxicity of Micro and Nano Plastics Combined With Environmental Contaminants on the Risk of Allergic Disease
|
||
Completed |
NCT01420705 -
Bacille Calmette-Guérin (BCG) Vaccine and Atopy
|
N/A | |
Completed |
NCT00850668 -
Peanut Allergy Vaccine Study in Healthy and Peanut-allergic Adults
|
Phase 1 | |
Withdrawn |
NCT00736112 -
Food Allergy - Tubes - Adenoids (FATA) Trial
|
N/A | |
Active, not recruiting |
NCT00298337 -
Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008
|
Phase 2/Phase 3 | |
Completed |
NCT03693456 -
Food Allergy Diagnostic Test Response to Previous Oral Challenge Response
|
N/A | |
Completed |
NCT00461097 -
Oral Immunotherapy for Childhood Egg Allergy
|
Phase 2 | |
Completed |
NCT02606721 -
Food Allergy Challenge Diagnostic Study
|
||
Active, not recruiting |
NCT02457416 -
Take Away Food Allergy; Inducing Tolerance in Children Allergic to Peanut
|
N/A | |
Completed |
NCT02825069 -
Study on the Induction of Food Tolerance in Babies
|
N/A | |
Completed |
NCT02350660 -
Oral Immunotherapy for Peanut and Mammalian Meat Allergies
|
N/A | |
Completed |
NCT01084174 -
A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy
|
Phase 1/Phase 2 | |
Completed |
NCT00597675 -
Oral Immunotherapy for Peanut Allergy (PMIT)
|
Phase 2 | |
Completed |
NCT00932828 -
Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study
|
Phase 2 | |
Completed |
NCT01373242 -
Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance
|
Phase 1/Phase 2 | |
Completed |
NCT00578656 -
An Interventional Study of Milk Allergy
|
Phase 0 | |
Completed |
NCT00356174 -
An Observational Study of Childhood Food Allergy
|
N/A |